Skip to main content

Table 1 Baseline characteristics of asymptomatic parasitaemic pregnant women enrolled in a modified in vivo efficacy study of sulphadoxine-pyrimethamine (SP), stratified by gravidity

From: In vivo efficacy of sulphadoxine-pyrimethamine for the treatment of asymptomatic parasitaemia in pregnant women in Machinga District, Malawi

  Total (N = 245) Primigravid (N = 114) Multigravid (N = 131) p-value
Age, mean (SD) 21.7 (5.0) 18.8 (2.9) 24.3 (5.0) <0.0001
Age ≤20 years 54.3% 87.7% 25.2% <0.0001
Bed net use     
Used a bed net last night 32.2% 21.9% 41.2% 0.001
Used an insecticide-treated bed net last night 27.3% 14.9% 38.2% <0.0001
Maternal weight (kg), mean (SD) 55.8 (7.1) 55.4 (6.9) 56.1 (7.3) 0.40
Education (years), mean (SD) 6.2 (3.0) 6.9 (2.9) 5.6 (3.0) <0.001
Perceived below average wealth status 78.0% 81.6% 74.6% 0.19
Gestational age at enrolment (weeks), mean (SD) 21.0 (3.9) 20.2 (3.6) 21.8 (4.0) 0.002
Haemoglobin at enrolment, mean (SD) 9.8 (1.3) 9.2 (1.1) 10.4 (1.3) <0.0001
Per cent of women with anaemia (Hb <11 g/dL) at enrolment 81.2% 96.5% 67.9% <0.0001
Per cent of women with gametocytaemia 0.4% 0.00% 0.8% -
Parasite density (parasites/ml), geometric mean (range) 273 (32–12,835) 372 (48–12,835) 209 (32–8,955) <0.0001
  1. SD = standard deviation, Hb = haemoglobin.